You have 9 free searches left this month | for more free features.

21-156

Showing 1 - 25 of 7,025

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hyperkalemia Trial in Worldwide (Patiromer, Placebos)

Completed
  • Hyperkalemia
  • Alexander City, Alabama
  • +414 more
Jan 11, 2022

Mepolizumab Treatment in Nasal Polyps With or Without Bronchial

Not yet recruiting
  • Chronic Rhinosinusitis With Nasal Polyps
  • Asthma
  • Mepolizumab 100 MG [Nucala]
  • Thessaloniki, Exochi, Greece
    Pulmonary Clinic of Aristotle University of Thessaloniki, George
Jan 23, 2023

Autosomal Dominant Polycystic Kidney Disease (ADPKD) Trial in Worldwide (Tolvaptan)

Completed
  • Autosomal Dominant Polycystic Kidney Disease (ADPKD)
  • Mobile, Alabama
  • +96 more
Sep 27, 2021

Molar Incisor Hypomineralization Trial in Irbid (Minimal invasive restorative treatment, Fluoride gel application)

Active, not recruiting
  • Molar Incisor Hypomineralization
  • Minimal invasive restorative treatment
  • Fluoride gel application
  • Irbid, Jordan
    Jordan University of Science and Technology
Feb 17, 2023

Schizophrenia Trial in New York (CT-156-C-001)

Recruiting
  • Schizophrenia
  • CT-156-C-001
  • New York, New York
    Click Therapeutics
Nov 13, 2023

Pulmonary Emphysema in Alpha-1 PI Deficiency Trial in Worldwide (Alpha-1 MP, 0.9% Sodium Chloride for Injection, USP)

Recruiting
  • Pulmonary Emphysema in Alpha-1 PI Deficiency
  • Alpha-1 MP
  • 0.9% Sodium Chloride for Injection, USP
  • Phoenix, Arizona
  • +50 more
Dec 7, 2022

Vasomotor Symptoms Associated With Menopause, Hot Flashes Trial in Worldwide (Elinzanetant (BAY3427080), Placebo)

Active, not recruiting
  • Vasomotor Symptoms Associated With Menopause
  • Hot Flashes
  • Elinzanetant (BAY3427080)
  • Placebo
  • Birmingham, Alabama
  • +98 more
Feb 2, 2023

Advanced Cancer, Metastatic Solid Tumor Trial in New York (Repotrectinib, Irinotecan and temozolomide)

Recruiting
  • Advanced Cancer
  • Metastatic Solid Tumor
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Dec 1, 2022

Atypical Antipsychotics Long-term Treatment Schizophrenia

Recruiting
  • Schizophrenia
    • Shanghai, Shanghai, China
      Shanghai Mental Health Center
    Sep 13, 2021

    Cardiovascular Diseases, Endothelial Dysfunction, Blood Pressure Trial in Coleraine (Polyphenol extract, Placebo)

    Recruiting
    • Cardiovascular Diseases
    • +2 more
    • Polyphenol extract
    • Placebo
    • Coleraine, Co.Londonderry, United Kingdom
      Human Intervention Studies Unit, Ulster University
    Mar 10, 2022

    Renal Replacement Therapy Trial in Guangzhou (HSK36273, Heparin sodium)

    Not yet recruiting
    • Renal Replacement Therapy
    • Guangzhou, China
      The First Affiliated Hospital of Sun Yat-sen University
    Nov 1, 2022

    LDL Cholesterol Trial in Granada (Cardiovascular Risk Prevention with a Mediterranean Dietary Pattern Reduced in Saturated Fat)

    Not yet recruiting
    • LDL Cholesterol
    • Cardiovascular Risk Prevention with a Mediterranean Dietary Pattern Reduced in Saturated Fat
    • Granada, Spain
      University of Granada
    Mar 9, 2023

    Uncomplicated Plasmodium Falciparum Malaria Trial (KLU156, Coartem)

    Not yet recruiting
    • Uncomplicated Plasmodium Falciparum Malaria
    • (no location specified)
    May 3, 2023

    Chronic Myelogenous Leukemia Trial in Worldwide (Asciminib, Bosutinib)

    Active, not recruiting
    • Chronic Myelogenous Leukemia
    • Chicago, Illinois
    • +87 more
    Jan 20, 2023

    Essential Thrombocythemia Trial (Bomedemstat, Anagrelide, Busulfan)

    Not yet recruiting
    • Essential Thrombocythemia
    • (no location specified)
    Oct 6, 2023

    Healthcare Resource Utilization in Adult Myelofibrosis Through

    Recruiting
    • Myelofibrosis
      • La Plata, Buenos Aires, Argentina
      • +62 more
      Feb 1, 2023

      Mucopolysaccharidosis II Trial in Salt Lake City, Fairfax (Genetic HMI-203)

      Recruiting
      • Mucopolysaccharidosis II
      • Genetic HMI-203
      • Oakland, California
      • +5 more
      Jan 26, 2023

      Diabetic Kidney Disease Trial in Worldwide (SEL, Placebo)

      Completed
      • Diabetic Kidney Disease
      • Glendale, Arizona
      • +110 more
      Nov 29, 2022

      Influenza, Human Trial in United States (NanoFlu (Quad-NIV), Matrix-M Adjuvant, Placebo)

      Terminated
      • Influenza, Human
      • NanoFlu (Quad-NIV)
      • +5 more
      • Hollywood, Florida
      • +13 more
      Nov 3, 2022

      NSCLC Trial in Worldwide (Nivolumab, Docetaxel)

      Active, not recruiting
      • Non-Small Cell Lung Cancer
      • Beijing, Beijing, China
      • +31 more
      Jul 21, 2022

      Migraine Without Aura, Migraine With Aura Trial in Worldwide (Placebo, Eletriptan HBr 40 mg, Eletriptan HBr 80 mg)

      Completed
      • Migraine Without Aura
      • Migraine With Aura
      • Placebo
      • +2 more
      • Antwerpen, Belgium
      • +147 more
      Jan 26, 2021

      Von Willebrand Diseases, Postpartum Hemorrhage Trial in Pittsburgh (Recombinant Von Willebrand factor, Tranexamic Acid Injection

      Recruiting
      • Von Willebrand Diseases
      • Postpartum Hemorrhage
      • Recombinant Von Willebrand factor
      • Tranexamic Acid Injection [Cyklokapron]
      • Pittsburgh, Pennsylvania
      • +1 more
      Jul 5, 2022

      Carcinoma, Hepatocellular Trial in Worldwide (Atezolizumab, Bevacizumab, Sorafenib)

      Active, not recruiting
      • Carcinoma, Hepatocellular
      • Phoenix, Arizona
      • +118 more
      Jun 14, 2022

      ALS, Amyotrophic Lateral Sclerosis Trial in Canada, United States (ABBV-CLS-7262, Placebo)

      Active, not recruiting
      • ALS
      • Amyotrophic Lateral Sclerosis
      • Irvine, California
      • +13 more
      Jan 20, 2023

      Primary Sclerosing Cholangitis Trial (Liver Multiscan sequences, Liver Multiscan analysis, MRCP+)

      Not yet recruiting
      • Primary Sclerosing Cholangitis
      • Liver Multiscan sequences
      • +2 more
      • (no location specified)
      Jul 13, 2022